News
Matthew Binnicker, Ph.D., director of Mayo Clinic’s Clinical Virology Laboratory, provides insight on the newest COVID-19 subvariant – XBB.1.16, also known as “Arcturus.”
Matthew Binnicker, Ph.D., director of Mayo Clinic’s Clinical Virology Laboratory, provides an update on the ongoing global avian influenza outbreak and what’s being done to prepare for a potential human-to-human outbreak.
Top highlights include: Adderall shortage is taking a toll, scientists are reconsidering the dangers of prospecting for unknown viruses, and can community paramedcine improve health outcomes in rural America?
Having an efficient and effective supply provision program is a cornerstone for laboratory outreach program success. By providing adequate specimen collection supplies in compliance with current regulations, the outreach laboratory-customer relationship is certain to succeed.
Mayo Clinic Laboratories is excited to participate in the American Academy of Neurology Annual Meeting, taking place in person in Boston on April 22–27, 2023.
Top highlights include: Government to launch $300M Azlheimer's research database, new COVID variant XBB.1.16 spotted in 18 US states, and novel treatment shows promise against rare cancer in kids.
In March 2023, Mayo Clinic Laboratories announced twenty nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Today's Highlights Include: US FDA seeks to allow salt substitutes in everyday foods, radioactive water leaks at Minn. nuclear plant for 2nd time, and pushback grows over mental health impacts of social media.
Mayo Clinic Laboratories is thrilled to participate in the American Academy of Neurology Annual Meeting 2023.
Today's highlights include: End of Covid emergency will usher in changes across the US health system, vaccine makers prep bird flu shot for humans ‘just in case’; rich nations lock in supplies, and a nuclear power plant leaked contaminated water in Minnesota.
Today's Highlights Include: Rochester public schools receives grant to support youth mental health, and FDA releases new regs intended to help detect breast cancer sooner.
In a post on Mayo Clinic’s News Network, Mayo Clinic’s director of Clinical Virology, Matthew Binnicker, Ph.D., explains the concern over a potential human-to-human outbreak of avian influenza and what’s being done at Mayo Clinic and elsewhere to mitigate that risk.
In February 2023, Mayo Clinic Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.